The ISR downstream target ATF4 represses long-term memory in a cell type-specific manner.
integrated stress response
learning and memory
protein synthesis
synaptic plasticity
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
30 Jul 2024
30 Jul 2024
Historique:
medline:
26
7
2024
pubmed:
26
7
2024
entrez:
24
7
2024
Statut:
ppublish
Résumé
The integrated stress response (ISR), a pivotal protein homeostasis network, plays a critical role in the formation of long-term memory (LTM). The precise mechanism by which the ISR controls LTM is not well understood. Here, we report insights into how the ISR modulates the mnemonic process by using targeted deletion of the activating transcription factor 4 (ATF4), a key downstream effector of the ISR, in various neuronal and non-neuronal cell types. We found that the removal of ATF4 from forebrain excitatory neurons (but not from inhibitory neurons, cholinergic neurons, or astrocytes) enhances LTM formation. Furthermore, the deletion of ATF4 in excitatory neurons lowers the threshold for the induction of long-term potentiation, a cellular model for LTM. Transcriptomic and proteomic analyses revealed that ATF4 deletion in excitatory neurons leads to upregulation of components of oxidative phosphorylation pathways, which are critical for ATP production. Thus, we conclude that ATF4 functions as a memory repressor selectively within excitatory neurons.
Identifiants
pubmed: 39047038
doi: 10.1073/pnas.2407472121
doi:
Substances chimiques
Activating Transcription Factor 4
145891-90-3
Atf4 protein, mouse
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2407472121Subventions
Organisme : Canadian Government | Canadian Institutes of Health Research (CIHR)
ID : FND-148423
Déclaration de conflit d'intérêts
Competing interests statement:M.C.-M. and S.W.D. are employees of Altos Labs, Inc. M.C.-M. is a shareholder of Altos Labs, Inc. and Mikrovia, Inc. All other authors do not declare any competing/conflicting interests.